CLASS II ONGOING Device recall · Reported 6 Apr 2022 · FDA Enforcement Report

Revogene, For In Vitro Diagnostic use recalled by Meridian Bioscience

Meridian Bioscience is recalling Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical, distributed nationwide in the US. The recall was initiated on 15 Feb 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 00840733102318 All units in the field, all serial numbers.
Quantity recalled452 units (398 US, 54 OUS)

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0836-2022
FDA event ID
89666
Recalling firm
Meridian Bioscience, Cincinnati, OH
Classification
Class II
Status
Ongoing
Recall initiated
15 Feb 2022
FDA classified
30 Mar 2022
Reported
6 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Feb 2022Recall initiated by company
30 Mar 2022Classified by FDA+43 days
6 Apr 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.

Product as listed by the FDA

Revogene, For In Vitro Diagnostic use in performing nucleic acid testing in clinical laboratories. Meridian branded Revogene: Catalog Number 610210 GenePOC branded Revogene: Catalog Number 130840

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, NE, NJ, NV, NY, OH, OR, PA, PR, RI, SD, TN, TX, UT, VA, VT, WI, WV and the countries of Australia, Chile, Italy, Switzerland.

Nationwide AlaskaAlabamaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMaineMichiganMinnesota

Questions about this recall

Why was it recalled?

The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.

Which lots are affected?

UDI: 00840733102318 All units in the field, all serial numbers.

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, ME, MI, MN, MO, MS, MT, NC, NE, NJ, NV, NY, OH, OR, PA, PR, RI, SD, TN, TX, UT, VA, VT, WI, WV and the countries of Australia, Chile, Italy, Switzerland.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Meridian Bioscience

All 15

Other Test Kits & Diagnostics recalls

All 2,663